
Reanalysis of Popular Antidepressant Trial Uncovers Reporting Flaws
0:00
8:14
- A reanalysis of a study found that fluoxetine alone showed no measurable benefit over placebo in treating adolescent depression after 12 weeks
- Researchers uncovered 11 additional suicide-related events that were hidden or misclassified, bringing the total to 21 serious incidents
- Statistical tactics and selective reporting made fluoxetine appear safer and more effective than it really was in clinical trials
- A different reanalysis mentioned that adverse events and many side effects were minimized or excluded from the original reports
- Improving gut health, getting regular exercise, undergoing therapy, and optimizing vitamin D are viable approaches for treating depression
D'autres épisodes de "Dr. Joseph Mercola - Take Control of Your Health"
Ne ratez aucun épisode de “Dr. Joseph Mercola - Take Control of Your Health” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.